Biora Therapeutics, Inc.
Biora Therapeutics, Inc. (BIORQ) Stock Competitors & Peer Comparison
See (BIORQ) competitors and their performances in Stock Market.
Peer Comparison Table: Biotechnology Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| BIORQ | $0.00 | +19900.00% | 905 | N/A | N/A | N/A |
| NONOF | $40.32 | -2.84% | 178.5B | 11.13 | $3.61 | +4.43% |
| CSLLY | $22.24 | -3.47% | 86.1B | 14.44 | $1.54 | +3.16% |
| UCBJF | $273.54 | -0.74% | 52.1B | 29.10 | $9.40 | +0.57% |
| UCBJY | $131.58 | -0.48% | 50.1B | 28.00 | $4.70 | +0.59% |
| ARGNF | $724.55 | -7.23% | 44.8B | 36.97 | $19.60 | N/A |
| CMXHF | $90.00 | -0.54% | 43.7B | 14.59 | $6.17 | +3.23% |
| WXIBF | $4.70 | +0.00% | 19.4B | 27.65 | $0.17 | N/A |
| IVBXF | $11.08 | +7.66% | 19.1B | 158.25 | $0.07 | N/A |
| WXXWY | $8.52 | -0.47% | 17.6B | 25.09 | $0.34 | N/A |
Stock Comparison
BIORQ vs NONOF Comparison April 2026
BIORQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIORQ stands at 905. In comparison, NONOF has a market cap of 178.5B. Regarding current trading prices, BIORQ is priced at $0.00, while NONOF trades at $40.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIORQ currently has a P/E ratio of N/A, whereas NONOF's P/E ratio is 11.13. In terms of profitability, BIORQ's ROE is +1.22%, compared to NONOF's ROE of +0.61%. Regarding short-term risk, BIORQ is more volatile compared to NONOF. This indicates potentially higher risk in terms of short-term price fluctuations for BIORQ.Check NONOF's competition here
BIORQ vs CSLLY Comparison April 2026
BIORQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIORQ stands at 905. In comparison, CSLLY has a market cap of 86.1B. Regarding current trading prices, BIORQ is priced at $0.00, while CSLLY trades at $22.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIORQ currently has a P/E ratio of N/A, whereas CSLLY's P/E ratio is 14.44. In terms of profitability, BIORQ's ROE is +1.22%, compared to CSLLY's ROE of +0.08%. Regarding short-term risk, BIORQ is more volatile compared to CSLLY. This indicates potentially higher risk in terms of short-term price fluctuations for BIORQ.Check CSLLY's competition here
BIORQ vs UCBJF Comparison April 2026
BIORQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIORQ stands at 905. In comparison, UCBJF has a market cap of 52.1B. Regarding current trading prices, BIORQ is priced at $0.00, while UCBJF trades at $273.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIORQ currently has a P/E ratio of N/A, whereas UCBJF's P/E ratio is 29.10. In terms of profitability, BIORQ's ROE is +1.22%, compared to UCBJF's ROE of +0.15%. Regarding short-term risk, BIORQ is more volatile compared to UCBJF. This indicates potentially higher risk in terms of short-term price fluctuations for BIORQ.Check UCBJF's competition here
BIORQ vs UCBJY Comparison April 2026
BIORQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIORQ stands at 905. In comparison, UCBJY has a market cap of 50.1B. Regarding current trading prices, BIORQ is priced at $0.00, while UCBJY trades at $131.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIORQ currently has a P/E ratio of N/A, whereas UCBJY's P/E ratio is 28.00. In terms of profitability, BIORQ's ROE is +1.22%, compared to UCBJY's ROE of +0.15%. Regarding short-term risk, BIORQ is more volatile compared to UCBJY. This indicates potentially higher risk in terms of short-term price fluctuations for BIORQ.Check UCBJY's competition here
BIORQ vs ARGNF Comparison April 2026
BIORQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIORQ stands at 905. In comparison, ARGNF has a market cap of 44.8B. Regarding current trading prices, BIORQ is priced at $0.00, while ARGNF trades at $724.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIORQ currently has a P/E ratio of N/A, whereas ARGNF's P/E ratio is 36.97. In terms of profitability, BIORQ's ROE is +1.22%, compared to ARGNF's ROE of +0.34%. Regarding short-term risk, BIORQ is more volatile compared to ARGNF. This indicates potentially higher risk in terms of short-term price fluctuations for BIORQ.Check ARGNF's competition here
BIORQ vs CMXHF Comparison April 2026
BIORQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIORQ stands at 905. In comparison, CMXHF has a market cap of 43.7B. Regarding current trading prices, BIORQ is priced at $0.00, while CMXHF trades at $90.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIORQ currently has a P/E ratio of N/A, whereas CMXHF's P/E ratio is 14.59. In terms of profitability, BIORQ's ROE is +1.22%, compared to CMXHF's ROE of +0.08%. Regarding short-term risk, BIORQ is more volatile compared to CMXHF. This indicates potentially higher risk in terms of short-term price fluctuations for BIORQ.Check CMXHF's competition here
BIORQ vs WXIBF Comparison April 2026
BIORQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIORQ stands at 905. In comparison, WXIBF has a market cap of 19.4B. Regarding current trading prices, BIORQ is priced at $0.00, while WXIBF trades at $4.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIORQ currently has a P/E ratio of N/A, whereas WXIBF's P/E ratio is 27.65. In terms of profitability, BIORQ's ROE is +1.22%, compared to WXIBF's ROE of +0.11%. Regarding short-term risk, BIORQ is more volatile compared to WXIBF. This indicates potentially higher risk in terms of short-term price fluctuations for BIORQ.Check WXIBF's competition here
BIORQ vs IVBXF Comparison April 2026
BIORQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIORQ stands at 905. In comparison, IVBXF has a market cap of 19.1B. Regarding current trading prices, BIORQ is priced at $0.00, while IVBXF trades at $11.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIORQ currently has a P/E ratio of N/A, whereas IVBXF's P/E ratio is 158.25. In terms of profitability, BIORQ's ROE is +1.22%, compared to IVBXF's ROE of +0.05%. Regarding short-term risk, BIORQ is more volatile compared to IVBXF. This indicates potentially higher risk in terms of short-term price fluctuations for BIORQ.Check IVBXF's competition here
BIORQ vs WXXWY Comparison April 2026
BIORQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIORQ stands at 905. In comparison, WXXWY has a market cap of 17.6B. Regarding current trading prices, BIORQ is priced at $0.00, while WXXWY trades at $8.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIORQ currently has a P/E ratio of N/A, whereas WXXWY's P/E ratio is 25.09. In terms of profitability, BIORQ's ROE is +1.22%, compared to WXXWY's ROE of +0.11%. Regarding short-term risk, BIORQ is more volatile compared to WXXWY. This indicates potentially higher risk in terms of short-term price fluctuations for BIORQ.Check WXXWY's competition here
BIORQ vs GNMSF Comparison April 2026
BIORQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIORQ stands at 905. In comparison, GNMSF has a market cap of 15.7B. Regarding current trading prices, BIORQ is priced at $0.00, while GNMSF trades at $255.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIORQ currently has a P/E ratio of N/A, whereas GNMSF's P/E ratio is 16.62. In terms of profitability, BIORQ's ROE is +1.22%, compared to GNMSF's ROE of +0.19%. Regarding short-term risk, BIORQ is more volatile compared to GNMSF. This indicates potentially higher risk in terms of short-term price fluctuations for BIORQ.Check GNMSF's competition here
BIORQ vs SBMFF Comparison April 2026
BIORQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIORQ stands at 905. In comparison, SBMFF has a market cap of 13.6B. Regarding current trading prices, BIORQ is priced at $0.00, while SBMFF trades at $0.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIORQ currently has a P/E ratio of N/A, whereas SBMFF's P/E ratio is 25.33. In terms of profitability, BIORQ's ROE is +1.22%, compared to SBMFF's ROE of +0.11%. Regarding short-term risk, BIORQ is more volatile compared to SBMFF. This indicates potentially higher risk in terms of short-term price fluctuations for BIORQ.Check SBMFF's competition here
BIORQ vs SBHMY Comparison April 2026
BIORQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIORQ stands at 905. In comparison, SBHMY has a market cap of 12.8B. Regarding current trading prices, BIORQ is priced at $0.00, while SBHMY trades at $14.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIORQ currently has a P/E ratio of N/A, whereas SBHMY's P/E ratio is 37.59. In terms of profitability, BIORQ's ROE is +1.22%, compared to SBHMY's ROE of +0.11%. Regarding short-term risk, BIORQ is more volatile compared to SBHMY. This indicates potentially higher risk in terms of short-term price fluctuations for BIORQ.Check SBHMY's competition here
BIORQ vs BRRGF Comparison April 2026
BIORQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIORQ stands at 905. In comparison, BRRGF has a market cap of 9.5B. Regarding current trading prices, BIORQ is priced at $0.00, while BRRGF trades at $97.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIORQ currently has a P/E ratio of N/A, whereas BRRGF's P/E ratio is -0.48. In terms of profitability, BIORQ's ROE is +1.22%, compared to BRRGF's ROE of -0.97%. Regarding short-term risk, BIORQ is less volatile compared to BRRGF. This indicates potentially lower risk in terms of short-term price fluctuations for BIORQ.Check BRRGF's competition here
BIORQ vs AAVXF Comparison April 2026
BIORQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIORQ stands at 905. In comparison, AAVXF has a market cap of 9.2B. Regarding current trading prices, BIORQ is priced at $0.00, while AAVXF trades at $115.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIORQ currently has a P/E ratio of N/A, whereas AAVXF's P/E ratio is -22.11. In terms of profitability, BIORQ's ROE is +1.22%, compared to AAVXF's ROE of -1.65%. Regarding short-term risk, BIORQ is more volatile compared to AAVXF. This indicates potentially higher risk in terms of short-term price fluctuations for BIORQ.Check AAVXF's competition here
BIORQ vs ODTC Comparison April 2026
BIORQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIORQ stands at 905. In comparison, ODTC has a market cap of 8B. Regarding current trading prices, BIORQ is priced at $0.00, while ODTC trades at $22,005.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIORQ currently has a P/E ratio of N/A, whereas ODTC's P/E ratio is 1.07. In terms of profitability, BIORQ's ROE is +1.22%, compared to ODTC's ROE of +0.07%. Regarding short-term risk, BIORQ is more volatile compared to ODTC. This indicates potentially higher risk in terms of short-term price fluctuations for BIORQ.Check ODTC's competition here
BIORQ vs AKBLF Comparison April 2026
BIORQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIORQ stands at 905. In comparison, AKBLF has a market cap of 7.2B. Regarding current trading prices, BIORQ is priced at $0.00, while AKBLF trades at $35.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIORQ currently has a P/E ratio of N/A, whereas AKBLF's P/E ratio is 41.83. In terms of profitability, BIORQ's ROE is +1.22%, compared to AKBLF's ROE of +0.20%. Regarding short-term risk, BIORQ is more volatile compared to AKBLF. This indicates potentially higher risk in terms of short-term price fluctuations for BIORQ.Check AKBLF's competition here
BIORQ vs TRSBF Comparison April 2026
BIORQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIORQ stands at 905. In comparison, TRSBF has a market cap of 6.7B. Regarding current trading prices, BIORQ is priced at $0.00, while TRSBF trades at $2.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIORQ currently has a P/E ratio of N/A, whereas TRSBF's P/E ratio is 20.18. In terms of profitability, BIORQ's ROE is +1.22%, compared to TRSBF's ROE of +0.38%. Regarding short-term risk, BIORQ is more volatile compared to TRSBF. This indicates potentially higher risk in terms of short-term price fluctuations for BIORQ.Check TRSBF's competition here
BIORQ vs REGMF Comparison April 2026
BIORQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIORQ stands at 905. In comparison, REGMF has a market cap of 6.2B. Regarding current trading prices, BIORQ is priced at $0.00, while REGMF trades at $10.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIORQ currently has a P/E ratio of N/A, whereas REGMF's P/E ratio is 57.63. In terms of profitability, BIORQ's ROE is +1.22%, compared to REGMF's ROE of +0.27%. Regarding short-term risk, BIORQ is more volatile compared to REGMF. This indicates potentially higher risk in terms of short-term price fluctuations for BIORQ.Check REGMF's competition here
BIORQ vs ABCZF Comparison April 2026
BIORQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIORQ stands at 905. In comparison, ABCZF has a market cap of 5.1B. Regarding current trading prices, BIORQ is priced at $0.00, while ABCZF trades at $22.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIORQ currently has a P/E ratio of N/A, whereas ABCZF's P/E ratio is 2225.00. In terms of profitability, BIORQ's ROE is +1.22%, compared to ABCZF's ROE of +0.29%. Regarding short-term risk, BIORQ is more volatile compared to ABCZF. This indicates potentially higher risk in terms of short-term price fluctuations for BIORQ.Check ABCZF's competition here
BIORQ vs LABFF Comparison April 2026
BIORQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIORQ stands at 905. In comparison, LABFF has a market cap of 4.6B. Regarding current trading prices, BIORQ is priced at $0.00, while LABFF trades at $90.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIORQ currently has a P/E ratio of N/A, whereas LABFF's P/E ratio is 28.95. In terms of profitability, BIORQ's ROE is +1.22%, compared to LABFF's ROE of +0.23%. Regarding short-term risk, BIORQ is more volatile compared to LABFF. This indicates potentially higher risk in terms of short-term price fluctuations for BIORQ.Check LABFF's competition here
BIORQ vs SHJBF Comparison April 2026
BIORQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIORQ stands at 905. In comparison, SHJBF has a market cap of 4.3B. Regarding current trading prices, BIORQ is priced at $0.00, while SHJBF trades at $3.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIORQ currently has a P/E ratio of N/A, whereas SHJBF's P/E ratio is -25.00. In terms of profitability, BIORQ's ROE is +1.22%, compared to SHJBF's ROE of -0.14%. Regarding short-term risk, BIORQ is more volatile compared to SHJBF. This indicates potentially higher risk in terms of short-term price fluctuations for BIORQ.Check SHJBF's competition here
BIORQ vs CAMRF Comparison April 2026
BIORQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIORQ stands at 905. In comparison, CAMRF has a market cap of 3.8B. Regarding current trading prices, BIORQ is priced at $0.00, while CAMRF trades at $63.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIORQ currently has a P/E ratio of N/A, whereas CAMRF's P/E ratio is 47.59. In terms of profitability, BIORQ's ROE is +1.22%, compared to CAMRF's ROE of +0.19%. Regarding short-term risk, BIORQ is more volatile compared to CAMRF. This indicates potentially higher risk in terms of short-term price fluctuations for BIORQ.Check CAMRF's competition here
BIORQ vs TLPPF Comparison April 2026
BIORQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIORQ stands at 905. In comparison, TLPPF has a market cap of 3.5B. Regarding current trading prices, BIORQ is priced at $0.00, while TLPPF trades at $10.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIORQ currently has a P/E ratio of N/A, whereas TLPPF's P/E ratio is -512.50. In terms of profitability, BIORQ's ROE is +1.22%, compared to TLPPF's ROE of -0.02%. Regarding short-term risk, BIORQ is more volatile compared to TLPPF. This indicates potentially higher risk in terms of short-term price fluctuations for BIORQ.Check TLPPF's competition here
BIORQ vs ZLDPF Comparison April 2026
BIORQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIORQ stands at 905. In comparison, ZLDPF has a market cap of 3.5B. Regarding current trading prices, BIORQ is priced at $0.00, while ZLDPF trades at $49.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIORQ currently has a P/E ratio of N/A, whereas ZLDPF's P/E ratio is 3.47. In terms of profitability, BIORQ's ROE is +1.22%, compared to ZLDPF's ROE of +0.48%. Regarding short-term risk, BIORQ is more volatile compared to ZLDPF. This indicates potentially higher risk in terms of short-term price fluctuations for BIORQ.Check ZLDPF's competition here
BIORQ vs ASPHF Comparison April 2026
BIORQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIORQ stands at 905. In comparison, ASPHF has a market cap of 3.2B. Regarding current trading prices, BIORQ is priced at $0.00, while ASPHF trades at $8.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIORQ currently has a P/E ratio of N/A, whereas ASPHF's P/E ratio is -16.00. In terms of profitability, BIORQ's ROE is +1.22%, compared to ASPHF's ROE of -0.73%. Regarding short-term risk, BIORQ is more volatile compared to ASPHF. This indicates potentially higher risk in terms of short-term price fluctuations for BIORQ.Check ASPHF's competition here
BIORQ vs GNNSF Comparison April 2026
BIORQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIORQ stands at 905. In comparison, GNNSF has a market cap of 3.1B. Regarding current trading prices, BIORQ is priced at $0.00, while GNNSF trades at $1.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIORQ currently has a P/E ratio of N/A, whereas GNNSF's P/E ratio is -5.68. In terms of profitability, BIORQ's ROE is +1.22%, compared to GNNSF's ROE of -0.13%. Regarding short-term risk, BIORQ is more volatile compared to GNNSF. This indicates potentially higher risk in terms of short-term price fluctuations for BIORQ.Check GNNSF's competition here
BIORQ vs BRCTF Comparison April 2026
BIORQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIORQ stands at 905. In comparison, BRCTF has a market cap of 2.9B. Regarding current trading prices, BIORQ is priced at $0.00, while BRCTF trades at $33.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIORQ currently has a P/E ratio of N/A, whereas BRCTF's P/E ratio is 26.42. In terms of profitability, BIORQ's ROE is +1.22%, compared to BRCTF's ROE of +0.52%. Regarding short-term risk, BIORQ is more volatile compared to BRCTF. This indicates potentially higher risk in terms of short-term price fluctuations for BIORQ.Check BRCTF's competition here
BIORQ vs MPSYF Comparison April 2026
BIORQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIORQ stands at 905. In comparison, MPSYF has a market cap of 2.8B. Regarding current trading prices, BIORQ is priced at $0.00, while MPSYF trades at $73.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIORQ currently has a P/E ratio of N/A, whereas MPSYF's P/E ratio is -12.13. In terms of profitability, BIORQ's ROE is +1.22%, compared to MPSYF's ROE of -1.84%. Regarding short-term risk, BIORQ is more volatile compared to MPSYF. This indicates potentially higher risk in terms of short-term price fluctuations for BIORQ.Check MPSYF's competition here
BIORQ vs BVNKF Comparison April 2026
BIORQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIORQ stands at 905. In comparison, BVNKF has a market cap of 2.4B. Regarding current trading prices, BIORQ is priced at $0.00, while BVNKF trades at $30.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIORQ currently has a P/E ratio of N/A, whereas BVNKF's P/E ratio is 11.13. In terms of profitability, BIORQ's ROE is +1.22%, compared to BVNKF's ROE of +0.11%. Regarding short-term risk, BIORQ is more volatile compared to BVNKF. This indicates potentially higher risk in terms of short-term price fluctuations for BIORQ.Check BVNKF's competition here
BIORQ vs ASCLF Comparison April 2026
BIORQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIORQ stands at 905. In comparison, ASCLF has a market cap of 2.3B. Regarding current trading prices, BIORQ is priced at $0.00, while ASCLF trades at $2.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIORQ currently has a P/E ratio of N/A, whereas ASCLF's P/E ratio is -43.90. In terms of profitability, BIORQ's ROE is +1.22%, compared to ASCLF's ROE of -0.19%. Regarding short-term risk, BIORQ is more volatile compared to ASCLF. This indicates potentially higher risk in terms of short-term price fluctuations for BIORQ.Check ASCLF's competition here
BIORQ vs INCPF Comparison April 2026
BIORQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIORQ stands at 905. In comparison, INCPF has a market cap of 2.3B. Regarding current trading prices, BIORQ is priced at $0.00, while INCPF trades at $1.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIORQ currently has a P/E ratio of N/A, whereas INCPF's P/E ratio is 25.83. In terms of profitability, BIORQ's ROE is +1.22%, compared to INCPF's ROE of +0.10%. Regarding short-term risk, BIORQ is more volatile compared to INCPF. This indicates potentially higher risk in terms of short-term price fluctuations for BIORQ.Check INCPF's competition here
BIORQ vs BVNRY Comparison April 2026
BIORQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIORQ stands at 905. In comparison, BVNRY has a market cap of 2.3B. Regarding current trading prices, BIORQ is priced at $0.00, while BVNRY trades at $9.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIORQ currently has a P/E ratio of N/A, whereas BVNRY's P/E ratio is 10.47. In terms of profitability, BIORQ's ROE is +1.22%, compared to BVNRY's ROE of +0.11%. Regarding short-term risk, BIORQ is more volatile compared to BVNRY. This indicates potentially higher risk in terms of short-term price fluctuations for BIORQ.Check BVNRY's competition here
BIORQ vs GENSF Comparison April 2026
BIORQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIORQ stands at 905. In comparison, GENSF has a market cap of 2.2B. Regarding current trading prices, BIORQ is priced at $0.00, while GENSF trades at $33.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIORQ currently has a P/E ratio of N/A, whereas GENSF's P/E ratio is 34.54. In terms of profitability, BIORQ's ROE is +1.22%, compared to GENSF's ROE of +0.10%. Regarding short-term risk, BIORQ is more volatile compared to GENSF. This indicates potentially higher risk in terms of short-term price fluctuations for BIORQ.Check GENSF's competition here
BIORQ vs MEOBF Comparison April 2026
BIORQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIORQ stands at 905. In comparison, MEOBF has a market cap of 2.2B. Regarding current trading prices, BIORQ is priced at $0.00, while MEOBF trades at $1.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIORQ currently has a P/E ratio of N/A, whereas MEOBF's P/E ratio is -24.29. In terms of profitability, BIORQ's ROE is +1.22%, compared to MEOBF's ROE of -0.14%. Regarding short-term risk, BIORQ is more volatile compared to MEOBF. This indicates potentially higher risk in terms of short-term price fluctuations for BIORQ.Check MEOBF's competition here
BIORQ vs GLPGF Comparison April 2026
BIORQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIORQ stands at 905. In comparison, GLPGF has a market cap of 1.9B. Regarding current trading prices, BIORQ is priced at $0.00, while GLPGF trades at $28.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIORQ currently has a P/E ratio of N/A, whereas GLPGF's P/E ratio is -3.50. In terms of profitability, BIORQ's ROE is +1.22%, compared to GLPGF's ROE of +0.11%. Regarding short-term risk, BIORQ is more volatile compared to GLPGF. This indicates potentially higher risk in terms of short-term price fluctuations for BIORQ.Check GLPGF's competition here
BIORQ vs PHMMF Comparison April 2026
BIORQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIORQ stands at 905. In comparison, PHMMF has a market cap of 1.8B. Regarding current trading prices, BIORQ is priced at $0.00, while PHMMF trades at $106.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIORQ currently has a P/E ratio of N/A, whereas PHMMF's P/E ratio is 46.29. In terms of profitability, BIORQ's ROE is +1.22%, compared to PHMMF's ROE of +0.35%. Regarding short-term risk, BIORQ is more volatile compared to PHMMF. This indicates potentially higher risk in terms of short-term price fluctuations for BIORQ.Check PHMMF's competition here
BIORQ vs CSPHF Comparison April 2026
BIORQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIORQ stands at 905. In comparison, CSPHF has a market cap of 1.6B. Regarding current trading prices, BIORQ is priced at $0.00, while CSPHF trades at $1.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIORQ currently has a P/E ratio of N/A, whereas CSPHF's P/E ratio is -20.20. In terms of profitability, BIORQ's ROE is +1.22%, compared to CSPHF's ROE of -0.64%. Regarding short-term risk, BIORQ is more volatile compared to CSPHF. This indicates potentially higher risk in terms of short-term price fluctuations for BIORQ.Check CSPHF's competition here
BIORQ vs BIESF Comparison April 2026
BIORQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIORQ stands at 905. In comparison, BIESF has a market cap of 1.6B. Regarding current trading prices, BIORQ is priced at $0.00, while BIESF trades at $32.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIORQ currently has a P/E ratio of N/A, whereas BIESF's P/E ratio is -44.44. In terms of profitability, BIORQ's ROE is +1.22%, compared to BIESF's ROE of -0.05%. Regarding short-term risk, BIORQ is more volatile compared to BIESF. This indicates potentially higher risk in terms of short-term price fluctuations for BIORQ.Check BIESF's competition here
BIORQ vs ONTTF Comparison April 2026
BIORQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIORQ stands at 905. In comparison, ONTTF has a market cap of 1.5B. Regarding current trading prices, BIORQ is priced at $0.00, while ONTTF trades at $1.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIORQ currently has a P/E ratio of N/A, whereas ONTTF's P/E ratio is -7.94. In terms of profitability, BIORQ's ROE is +1.22%, compared to ONTTF's ROE of -0.29%. Regarding short-term risk, BIORQ is more volatile compared to ONTTF. This indicates potentially higher risk in terms of short-term price fluctuations for BIORQ.Check ONTTF's competition here
BIORQ vs HBMHF Comparison April 2026
BIORQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIORQ stands at 905. In comparison, HBMHF has a market cap of 1.3B. Regarding current trading prices, BIORQ is priced at $0.00, while HBMHF trades at $1.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIORQ currently has a P/E ratio of N/A, whereas HBMHF's P/E ratio is 17.33. In terms of profitability, BIORQ's ROE is +1.22%, compared to HBMHF's ROE of +0.36%. Regarding short-term risk, BIORQ is more volatile compared to HBMHF. This indicates potentially higher risk in terms of short-term price fluctuations for BIORQ.Check HBMHF's competition here
BIORQ vs SNBIF Comparison April 2026
BIORQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIORQ stands at 905. In comparison, SNBIF has a market cap of 1.3B. Regarding current trading prices, BIORQ is priced at $0.00, while SNBIF trades at $16.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIORQ currently has a P/E ratio of N/A, whereas SNBIF's P/E ratio is -49.85. In terms of profitability, BIORQ's ROE is +1.22%, compared to SNBIF's ROE of -0.89%. Regarding short-term risk, BIORQ is less volatile compared to SNBIF. This indicates potentially lower risk in terms of short-term price fluctuations for BIORQ.Check SNBIF's competition here
BIORQ vs PHGUF Comparison April 2026
BIORQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIORQ stands at 905. In comparison, PHGUF has a market cap of 1.2B. Regarding current trading prices, BIORQ is priced at $0.00, while PHGUF trades at $1.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIORQ currently has a P/E ratio of N/A, whereas PHGUF's P/E ratio is -175.00. In terms of profitability, BIORQ's ROE is +1.22%, compared to PHGUF's ROE of +0.01%. Regarding short-term risk, BIORQ is more volatile compared to PHGUF. This indicates potentially higher risk in terms of short-term price fluctuations for BIORQ.Check PHGUF's competition here
BIORQ vs MDCLF Comparison April 2026
BIORQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIORQ stands at 905. In comparison, MDCLF has a market cap of 1.2B. Regarding current trading prices, BIORQ is priced at $0.00, while MDCLF trades at $34.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIORQ currently has a P/E ratio of N/A, whereas MDCLF's P/E ratio is -47.76. In terms of profitability, BIORQ's ROE is +1.22%, compared to MDCLF's ROE of +0.84%. Regarding short-term risk, BIORQ is more volatile compared to MDCLF. This indicates potentially higher risk in terms of short-term price fluctuations for BIORQ.Check MDCLF's competition here
BIORQ vs NURPF Comparison April 2026
BIORQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIORQ stands at 905. In comparison, NURPF has a market cap of 1.1B. Regarding current trading prices, BIORQ is priced at $0.00, while NURPF trades at $8.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIORQ currently has a P/E ratio of N/A, whereas NURPF's P/E ratio is 51.91. In terms of profitability, BIORQ's ROE is +1.22%, compared to NURPF's ROE of +0.09%. Regarding short-term risk, BIORQ is more volatile compared to NURPF. This indicates potentially higher risk in terms of short-term price fluctuations for BIORQ.Check NURPF's competition here
BIORQ vs CSBTF Comparison April 2026
BIORQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIORQ stands at 905. In comparison, CSBTF has a market cap of 1.1B. Regarding current trading prices, BIORQ is priced at $0.00, while CSBTF trades at $28.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIORQ currently has a P/E ratio of N/A, whereas CSBTF's P/E ratio is 350.00. In terms of profitability, BIORQ's ROE is +1.22%, compared to CSBTF's ROE of +0.02%. Regarding short-term risk, BIORQ is more volatile compared to CSBTF. This indicates potentially higher risk in terms of short-term price fluctuations for BIORQ.Check CSBTF's competition here
BIORQ vs IDRSF Comparison April 2026
BIORQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIORQ stands at 905. In comparison, IDRSF has a market cap of 1.1B. Regarding current trading prices, BIORQ is priced at $0.00, while IDRSF trades at $4.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIORQ currently has a P/E ratio of N/A, whereas IDRSF's P/E ratio is -6.55. In terms of profitability, BIORQ's ROE is +1.22%, compared to IDRSF's ROE of +0.10%. Regarding short-term risk, BIORQ is more volatile compared to IDRSF. This indicates potentially higher risk in terms of short-term price fluctuations for BIORQ.Check IDRSF's competition here
BIORQ vs BTTAY Comparison April 2026
BIORQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIORQ stands at 905. In comparison, BTTAY has a market cap of 943M. Regarding current trading prices, BIORQ is priced at $0.00, while BTTAY trades at $24.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIORQ currently has a P/E ratio of N/A, whereas BTTAY's P/E ratio is -67.31. In terms of profitability, BIORQ's ROE is +1.22%, compared to BTTAY's ROE of -0.05%. Regarding short-term risk, BIORQ is more volatile compared to BTTAY. This indicates potentially higher risk in terms of short-term price fluctuations for BIORQ.Check BTTAY's competition here
BIORQ vs PPTDF Comparison April 2026
BIORQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIORQ stands at 905. In comparison, PPTDF has a market cap of 934.2M. Regarding current trading prices, BIORQ is priced at $0.00, while PPTDF trades at $7.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIORQ currently has a P/E ratio of N/A, whereas PPTDF's P/E ratio is -40.17. In terms of profitability, BIORQ's ROE is +1.22%, compared to PPTDF's ROE of -0.03%. Regarding short-term risk, BIORQ is more volatile compared to PPTDF. This indicates potentially higher risk in terms of short-term price fluctuations for BIORQ.Check PPTDF's competition here
BIORQ vs TKBIF Comparison April 2026
BIORQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIORQ stands at 905. In comparison, TKBIF has a market cap of 879M. Regarding current trading prices, BIORQ is priced at $0.00, while TKBIF trades at $7.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIORQ currently has a P/E ratio of N/A, whereas TKBIF's P/E ratio is -22.12. In terms of profitability, BIORQ's ROE is +1.22%, compared to TKBIF's ROE of N/A. Regarding short-term risk, BIORQ is less volatile compared to TKBIF. This indicates potentially lower risk in terms of short-term price fluctuations for BIORQ.Check TKBIF's competition here
BIORQ vs BPMUF Comparison April 2026
BIORQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIORQ stands at 905. In comparison, BPMUF has a market cap of 846.9M. Regarding current trading prices, BIORQ is priced at $0.00, while BPMUF trades at $69.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIORQ currently has a P/E ratio of N/A, whereas BPMUF's P/E ratio is 9.69. In terms of profitability, BIORQ's ROE is +1.22%, compared to BPMUF's ROE of +0.35%. Regarding short-term risk, BIORQ is more volatile compared to BPMUF. This indicates potentially higher risk in terms of short-term price fluctuations for BIORQ.Check BPMUF's competition here
BIORQ vs IVEVF Comparison April 2026
BIORQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIORQ stands at 905. In comparison, IVEVF has a market cap of 741.2M. Regarding current trading prices, BIORQ is priced at $0.00, while IVEVF trades at $5.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIORQ currently has a P/E ratio of N/A, whereas IVEVF's P/E ratio is -2.40. In terms of profitability, BIORQ's ROE is +1.22%, compared to IVEVF's ROE of +18.92%. Regarding short-term risk, BIORQ is more volatile compared to IVEVF. This indicates potentially higher risk in terms of short-term price fluctuations for BIORQ.Check IVEVF's competition here
BIORQ vs VBIZF Comparison April 2026
BIORQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIORQ stands at 905. In comparison, VBIZF has a market cap of 725M. Regarding current trading prices, BIORQ is priced at $0.00, while VBIZF trades at $0.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIORQ currently has a P/E ratio of N/A, whereas VBIZF's P/E ratio is 34.34. In terms of profitability, BIORQ's ROE is +1.22%, compared to VBIZF's ROE of +0.06%. Regarding short-term risk, BIORQ is more volatile compared to VBIZF. This indicates potentially higher risk in terms of short-term price fluctuations for BIORQ.Check VBIZF's competition here
BIORQ vs CKDXF Comparison April 2026
BIORQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIORQ stands at 905. In comparison, CKDXF has a market cap of 601.9M. Regarding current trading prices, BIORQ is priced at $0.00, while CKDXF trades at $0.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIORQ currently has a P/E ratio of N/A, whereas CKDXF's P/E ratio is -1.26. In terms of profitability, BIORQ's ROE is +1.22%, compared to CKDXF's ROE of +0.84%. Regarding short-term risk, BIORQ is more volatile compared to CKDXF. This indicates potentially higher risk in terms of short-term price fluctuations for BIORQ.Check CKDXF's competition here
BIORQ vs SOLTF Comparison April 2026
BIORQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIORQ stands at 905. In comparison, SOLTF has a market cap of 583.7M. Regarding current trading prices, BIORQ is priced at $0.00, while SOLTF trades at $6.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIORQ currently has a P/E ratio of N/A, whereas SOLTF's P/E ratio is -7.41. In terms of profitability, BIORQ's ROE is +1.22%, compared to SOLTF's ROE of -0.19%. Regarding short-term risk, BIORQ is more volatile compared to SOLTF. This indicates potentially higher risk in terms of short-term price fluctuations for BIORQ.Check SOLTF's competition here
BIORQ vs GNFTF Comparison April 2026
BIORQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIORQ stands at 905. In comparison, GNFTF has a market cap of 553.4M. Regarding current trading prices, BIORQ is priced at $0.00, while GNFTF trades at $11.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIORQ currently has a P/E ratio of N/A, whereas GNFTF's P/E ratio is -5.50. In terms of profitability, BIORQ's ROE is +1.22%, compared to GNFTF's ROE of -5.96%. Regarding short-term risk, BIORQ is more volatile compared to GNFTF. This indicates potentially higher risk in terms of short-term price fluctuations for BIORQ.Check GNFTF's competition here
BIORQ vs INRLF Comparison April 2026
BIORQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIORQ stands at 905. In comparison, INRLF has a market cap of 542.1M. Regarding current trading prices, BIORQ is priced at $0.00, while INRLF trades at $3.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIORQ currently has a P/E ratio of N/A, whereas INRLF's P/E ratio is -3.94. In terms of profitability, BIORQ's ROE is +1.22%, compared to INRLF's ROE of -0.75%. Regarding short-term risk, BIORQ is more volatile compared to INRLF. This indicates potentially higher risk in terms of short-term price fluctuations for BIORQ.Check INRLF's competition here
BIORQ vs RAONF Comparison April 2026
BIORQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIORQ stands at 905. In comparison, RAONF has a market cap of 451.7M. Regarding current trading prices, BIORQ is priced at $0.00, while RAONF trades at $2.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIORQ currently has a P/E ratio of N/A, whereas RAONF's P/E ratio is -43.33. In terms of profitability, BIORQ's ROE is +1.22%, compared to RAONF's ROE of -0.26%. Regarding short-term risk, BIORQ is less volatile compared to RAONF. This indicates potentially lower risk in terms of short-term price fluctuations for BIORQ.Check RAONF's competition here
BIORQ vs GNFTY Comparison April 2026
BIORQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIORQ stands at 905. In comparison, GNFTY has a market cap of 447.8M. Regarding current trading prices, BIORQ is priced at $0.00, while GNFTY trades at $8.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIORQ currently has a P/E ratio of N/A, whereas GNFTY's P/E ratio is -9.94. In terms of profitability, BIORQ's ROE is +1.22%, compared to GNFTY's ROE of -0.69%. Regarding short-term risk, BIORQ is more volatile compared to GNFTY. This indicates potentially higher risk in terms of short-term price fluctuations for BIORQ.Check GNFTY's competition here
BIORQ vs TBGNF Comparison April 2026
BIORQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIORQ stands at 905. In comparison, TBGNF has a market cap of 433.7M. Regarding current trading prices, BIORQ is priced at $0.00, while TBGNF trades at $0.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIORQ currently has a P/E ratio of N/A, whereas TBGNF's P/E ratio is -0.25. In terms of profitability, BIORQ's ROE is +1.22%, compared to TBGNF's ROE of -0.01%. Regarding short-term risk, BIORQ is more volatile compared to TBGNF. This indicates potentially higher risk in terms of short-term price fluctuations for BIORQ.Check TBGNF's competition here
BIORQ vs PTCHF Comparison April 2026
BIORQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIORQ stands at 905. In comparison, PTCHF has a market cap of 428.4M. Regarding current trading prices, BIORQ is priced at $0.00, while PTCHF trades at $1.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIORQ currently has a P/E ratio of N/A, whereas PTCHF's P/E ratio is 10.35. In terms of profitability, BIORQ's ROE is +1.22%, compared to PTCHF's ROE of +0.13%. Regarding short-term risk, BIORQ is more volatile compared to PTCHF. This indicates potentially higher risk in terms of short-term price fluctuations for BIORQ.Check PTCHF's competition here
BIORQ vs CYDY Comparison April 2026
BIORQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIORQ stands at 905. In comparison, CYDY has a market cap of 426.2M. Regarding current trading prices, BIORQ is priced at $0.00, while CYDY trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIORQ currently has a P/E ratio of N/A, whereas CYDY's P/E ratio is -7.80. In terms of profitability, BIORQ's ROE is +1.22%, compared to CYDY's ROE of +0.37%. Regarding short-term risk, BIORQ is more volatile compared to CYDY. This indicates potentially higher risk in terms of short-term price fluctuations for BIORQ.Check CYDY's competition here
BIORQ vs AVCTF Comparison April 2026
BIORQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIORQ stands at 905. In comparison, AVCTF has a market cap of 425M. Regarding current trading prices, BIORQ is priced at $0.00, while AVCTF trades at $0.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIORQ currently has a P/E ratio of N/A, whereas AVCTF's P/E ratio is -6.48. In terms of profitability, BIORQ's ROE is +1.22%, compared to AVCTF's ROE of -3.76%. Regarding short-term risk, BIORQ is more volatile compared to AVCTF. This indicates potentially higher risk in terms of short-term price fluctuations for BIORQ.Check AVCTF's competition here
BIORQ vs NWPHF Comparison April 2026
BIORQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIORQ stands at 905. In comparison, NWPHF has a market cap of 399.3M. Regarding current trading prices, BIORQ is priced at $0.00, while NWPHF trades at $20.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIORQ currently has a P/E ratio of N/A, whereas NWPHF's P/E ratio is N/A. In terms of profitability, BIORQ's ROE is +1.22%, compared to NWPHF's ROE of +16.69%. Regarding short-term risk, BIORQ is less volatile compared to NWPHF. This indicates potentially lower risk in terms of short-term price fluctuations for BIORQ.Check NWPHF's competition here
BIORQ vs CLVLY Comparison April 2026
BIORQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIORQ stands at 905. In comparison, CLVLY has a market cap of 342.1M. Regarding current trading prices, BIORQ is priced at $0.00, while CLVLY trades at $6.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIORQ currently has a P/E ratio of N/A, whereas CLVLY's P/E ratio is 14.75. In terms of profitability, BIORQ's ROE is +1.22%, compared to CLVLY's ROE of +0.13%. Regarding short-term risk, BIORQ is more volatile compared to CLVLY. This indicates potentially higher risk in terms of short-term price fluctuations for BIORQ.Check CLVLY's competition here
BIORQ vs SLNCF Comparison April 2026
BIORQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIORQ stands at 905. In comparison, SLNCF has a market cap of 334.4M. Regarding current trading prices, BIORQ is priced at $0.00, while SLNCF trades at $2.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIORQ currently has a P/E ratio of N/A, whereas SLNCF's P/E ratio is -3.75. In terms of profitability, BIORQ's ROE is +1.22%, compared to SLNCF's ROE of -3.59%. Regarding short-term risk, BIORQ is more volatile compared to SLNCF. This indicates potentially higher risk in terms of short-term price fluctuations for BIORQ.Check SLNCF's competition here
BIORQ vs SPHDF Comparison April 2026
BIORQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIORQ stands at 905. In comparison, SPHDF has a market cap of 330.6M. Regarding current trading prices, BIORQ is priced at $0.00, while SPHDF trades at $23.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIORQ currently has a P/E ratio of N/A, whereas SPHDF's P/E ratio is -3.40. In terms of profitability, BIORQ's ROE is +1.22%, compared to SPHDF's ROE of -5.22%. Regarding short-term risk, BIORQ is more volatile compared to SPHDF. This indicates potentially higher risk in terms of short-term price fluctuations for BIORQ.Check SPHDF's competition here
BIORQ vs NWBO Comparison April 2026
BIORQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIORQ stands at 905. In comparison, NWBO has a market cap of 321.4M. Regarding current trading prices, BIORQ is priced at $0.00, while NWBO trades at $0.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIORQ currently has a P/E ratio of N/A, whereas NWBO's P/E ratio is -5.00. In terms of profitability, BIORQ's ROE is +1.22%, compared to NWBO's ROE of +0.71%. Regarding short-term risk, BIORQ is more volatile compared to NWBO. This indicates potentially higher risk in terms of short-term price fluctuations for BIORQ.Check NWBO's competition here
BIORQ vs CLVLF Comparison April 2026
BIORQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIORQ stands at 905. In comparison, CLVLF has a market cap of 316.1M. Regarding current trading prices, BIORQ is priced at $0.00, while CLVLF trades at $6.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIORQ currently has a P/E ratio of N/A, whereas CLVLF's P/E ratio is 12.54. In terms of profitability, BIORQ's ROE is +1.22%, compared to CLVLF's ROE of +0.13%. Regarding short-term risk, BIORQ is more volatile compared to CLVLF. This indicates potentially higher risk in terms of short-term price fluctuations for BIORQ.Check CLVLF's competition here
BIORQ vs NGENF Comparison April 2026
BIORQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIORQ stands at 905. In comparison, NGENF has a market cap of 312.9M. Regarding current trading prices, BIORQ is priced at $0.00, while NGENF trades at $3.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIORQ currently has a P/E ratio of N/A, whereas NGENF's P/E ratio is -15.19. In terms of profitability, BIORQ's ROE is +1.22%, compared to NGENF's ROE of -974.60%. Regarding short-term risk, BIORQ is more volatile compared to NGENF. This indicates potentially higher risk in terms of short-term price fluctuations for BIORQ.Check NGENF's competition here
BIORQ vs FGHQF Comparison April 2026
BIORQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIORQ stands at 905. In comparison, FGHQF has a market cap of 304.2M. Regarding current trading prices, BIORQ is priced at $0.00, while FGHQF trades at $0.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIORQ currently has a P/E ratio of N/A, whereas FGHQF's P/E ratio is 15.00. In terms of profitability, BIORQ's ROE is +1.22%, compared to FGHQF's ROE of +0.02%. Regarding short-term risk, BIORQ is more volatile compared to FGHQF. This indicates potentially higher risk in terms of short-term price fluctuations for BIORQ.Check FGHQF's competition here
BIORQ vs PBBIF Comparison April 2026
BIORQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIORQ stands at 905. In comparison, PBBIF has a market cap of 286.9M. Regarding current trading prices, BIORQ is priced at $0.00, while PBBIF trades at $24.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIORQ currently has a P/E ratio of N/A, whereas PBBIF's P/E ratio is 266.67. In terms of profitability, BIORQ's ROE is +1.22%, compared to PBBIF's ROE of +0.01%. Regarding short-term risk, BIORQ is more volatile compared to PBBIF. This indicates potentially higher risk in terms of short-term price fluctuations for BIORQ.Check PBBIF's competition here
BIORQ vs ORPOF Comparison April 2026
BIORQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIORQ stands at 905. In comparison, ORPOF has a market cap of 260.3M. Regarding current trading prices, BIORQ is priced at $0.00, while ORPOF trades at $11.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIORQ currently has a P/E ratio of N/A, whereas ORPOF's P/E ratio is -11.86. In terms of profitability, BIORQ's ROE is +1.22%, compared to ORPOF's ROE of N/A. Regarding short-term risk, BIORQ is more volatile compared to ORPOF. This indicates potentially higher risk in terms of short-term price fluctuations for BIORQ.Check ORPOF's competition here
BIORQ vs ORYZF Comparison April 2026
BIORQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIORQ stands at 905. In comparison, ORYZF has a market cap of 258.9M. Regarding current trading prices, BIORQ is priced at $0.00, while ORYZF trades at $3.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIORQ currently has a P/E ratio of N/A, whereas ORYZF's P/E ratio is -83.50. In terms of profitability, BIORQ's ROE is +1.22%, compared to ORYZF's ROE of -0.03%. Regarding short-term risk, BIORQ is more volatile compared to ORYZF. This indicates potentially higher risk in terms of short-term price fluctuations for BIORQ.Check ORYZF's competition here
BIORQ vs HLOSF Comparison April 2026
BIORQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIORQ stands at 905. In comparison, HLOSF has a market cap of 247.6M. Regarding current trading prices, BIORQ is priced at $0.00, while HLOSF trades at $2.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIORQ currently has a P/E ratio of N/A, whereas HLOSF's P/E ratio is -13.53. In terms of profitability, BIORQ's ROE is +1.22%, compared to HLOSF's ROE of -0.80%. Regarding short-term risk, BIORQ is more volatile compared to HLOSF. This indicates potentially higher risk in terms of short-term price fluctuations for BIORQ.Check HLOSF's competition here
BIORQ vs HNSBF Comparison April 2026
BIORQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIORQ stands at 905. In comparison, HNSBF has a market cap of 245.8M. Regarding current trading prices, BIORQ is priced at $0.00, while HNSBF trades at $2.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIORQ currently has a P/E ratio of N/A, whereas HNSBF's P/E ratio is -4.08. In terms of profitability, BIORQ's ROE is +1.22%, compared to HNSBF's ROE of +2.02%. Regarding short-term risk, BIORQ is more volatile compared to HNSBF. This indicates potentially higher risk in terms of short-term price fluctuations for BIORQ.Check HNSBF's competition here
BIORQ vs CMVLF Comparison April 2026
BIORQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIORQ stands at 905. In comparison, CMVLF has a market cap of 222.8M. Regarding current trading prices, BIORQ is priced at $0.00, while CMVLF trades at $3.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIORQ currently has a P/E ratio of N/A, whereas CMVLF's P/E ratio is -4.60. In terms of profitability, BIORQ's ROE is +1.22%, compared to CMVLF's ROE of -0.70%. Regarding short-term risk, BIORQ is more volatile compared to CMVLF. This indicates potentially higher risk in terms of short-term price fluctuations for BIORQ.Check CMVLF's competition here
BIORQ vs CAIHF Comparison April 2026
BIORQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIORQ stands at 905. In comparison, CAIHF has a market cap of 217.4M. Regarding current trading prices, BIORQ is priced at $0.00, while CAIHF trades at $0.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIORQ currently has a P/E ratio of N/A, whereas CAIHF's P/E ratio is 2.80. In terms of profitability, BIORQ's ROE is +1.22%, compared to CAIHF's ROE of +0.12%. Regarding short-term risk, BIORQ is less volatile compared to CAIHF. This indicates potentially lower risk in terms of short-term price fluctuations for BIORQ.Check CAIHF's competition here
BIORQ vs BOVNF Comparison April 2026
BIORQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIORQ stands at 905. In comparison, BOVNF has a market cap of 216.4M. Regarding current trading prices, BIORQ is priced at $0.00, while BOVNF trades at $3.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIORQ currently has a P/E ratio of N/A, whereas BOVNF's P/E ratio is -7.00. In terms of profitability, BIORQ's ROE is +1.22%, compared to BOVNF's ROE of -0.47%. Regarding short-term risk, BIORQ is more volatile compared to BOVNF. This indicates potentially higher risk in terms of short-term price fluctuations for BIORQ.Check BOVNF's competition here
BIORQ vs FPHAF Comparison April 2026
BIORQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIORQ stands at 905. In comparison, FPHAF has a market cap of 209.5M. Regarding current trading prices, BIORQ is priced at $0.00, while FPHAF trades at $3.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIORQ currently has a P/E ratio of N/A, whereas FPHAF's P/E ratio is -7.50. In terms of profitability, BIORQ's ROE is +1.22%, compared to FPHAF's ROE of +0.00%. Regarding short-term risk, BIORQ is more volatile compared to FPHAF. This indicates potentially higher risk in terms of short-term price fluctuations for BIORQ.Check FPHAF's competition here
BIORQ vs SPHRY Comparison April 2026
BIORQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIORQ stands at 905. In comparison, SPHRY has a market cap of 196.6M. Regarding current trading prices, BIORQ is priced at $0.00, while SPHRY trades at $4.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIORQ currently has a P/E ratio of N/A, whereas SPHRY's P/E ratio is -77.83. In terms of profitability, BIORQ's ROE is +1.22%, compared to SPHRY's ROE of -0.05%. Regarding short-term risk, BIORQ is more volatile compared to SPHRY. This indicates potentially higher risk in terms of short-term price fluctuations for BIORQ.Check SPHRY's competition here
BIORQ vs SCNLF Comparison April 2026
BIORQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIORQ stands at 905. In comparison, SCNLF has a market cap of 176.3M. Regarding current trading prices, BIORQ is priced at $0.00, while SCNLF trades at $0.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIORQ currently has a P/E ratio of N/A, whereas SCNLF's P/E ratio is -16.99. In terms of profitability, BIORQ's ROE is +1.22%, compared to SCNLF's ROE of +0.90%. Regarding short-term risk, BIORQ is more volatile compared to SCNLF. This indicates potentially higher risk in terms of short-term price fluctuations for BIORQ.Check SCNLF's competition here
BIORQ vs KNTPF Comparison April 2026
BIORQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIORQ stands at 905. In comparison, KNTPF has a market cap of 172.3M. Regarding current trading prices, BIORQ is priced at $0.00, while KNTPF trades at $0.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIORQ currently has a P/E ratio of N/A, whereas KNTPF's P/E ratio is -6.12. In terms of profitability, BIORQ's ROE is +1.22%, compared to KNTPF's ROE of -0.63%. Regarding short-term risk, BIORQ is more volatile compared to KNTPF. This indicates potentially higher risk in terms of short-term price fluctuations for BIORQ.Check KNTPF's competition here
BIORQ vs ADOCY Comparison April 2026
BIORQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIORQ stands at 905. In comparison, ADOCY has a market cap of 170.4M. Regarding current trading prices, BIORQ is priced at $0.00, while ADOCY trades at $11.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIORQ currently has a P/E ratio of N/A, whereas ADOCY's P/E ratio is -3.36. In terms of profitability, BIORQ's ROE is +1.22%, compared to ADOCY's ROE of +8.60%. Regarding short-term risk, BIORQ is more volatile compared to ADOCY. This indicates potentially higher risk in terms of short-term price fluctuations for BIORQ.Check ADOCY's competition here
BIORQ vs BBIXF Comparison April 2026
BIORQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIORQ stands at 905. In comparison, BBIXF has a market cap of 151.8M. Regarding current trading prices, BIORQ is priced at $0.00, while BBIXF trades at $0.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIORQ currently has a P/E ratio of N/A, whereas BBIXF's P/E ratio is -13.00. In terms of profitability, BIORQ's ROE is +1.22%, compared to BBIXF's ROE of -15.41%. Regarding short-term risk, BIORQ is less volatile compared to BBIXF. This indicates potentially lower risk in terms of short-term price fluctuations for BIORQ.Check BBIXF's competition here
BIORQ vs SPHRF Comparison April 2026
BIORQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIORQ stands at 905. In comparison, SPHRF has a market cap of 147.3M. Regarding current trading prices, BIORQ is priced at $0.00, while SPHRF trades at $0.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIORQ currently has a P/E ratio of N/A, whereas SPHRF's P/E ratio is -35.00. In terms of profitability, BIORQ's ROE is +1.22%, compared to SPHRF's ROE of -0.16%. Regarding short-term risk, BIORQ is more volatile compared to SPHRF. This indicates potentially higher risk in terms of short-term price fluctuations for BIORQ.Check SPHRF's competition here
BIORQ vs AMGXF Comparison April 2026
BIORQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIORQ stands at 905. In comparison, AMGXF has a market cap of 142.5M. Regarding current trading prices, BIORQ is priced at $0.00, while AMGXF trades at $0.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIORQ currently has a P/E ratio of N/A, whereas AMGXF's P/E ratio is -0.46. In terms of profitability, BIORQ's ROE is +1.22%, compared to AMGXF's ROE of -0.45%. Regarding short-term risk, BIORQ is more volatile compared to AMGXF. This indicates potentially higher risk in terms of short-term price fluctuations for BIORQ.Check AMGXF's competition here
BIORQ vs IPHYF Comparison April 2026
BIORQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIORQ stands at 905. In comparison, IPHYF has a market cap of 140.7M. Regarding current trading prices, BIORQ is priced at $0.00, while IPHYF trades at $1.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIORQ currently has a P/E ratio of N/A, whereas IPHYF's P/E ratio is -2.31. In terms of profitability, BIORQ's ROE is +1.22%, compared to IPHYF's ROE of +5.94%. Regarding short-term risk, BIORQ is more volatile compared to IPHYF. This indicates potentially higher risk in terms of short-term price fluctuations for BIORQ.Check IPHYF's competition here
BIORQ vs BRIBF Comparison April 2026
BIORQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIORQ stands at 905. In comparison, BRIBF has a market cap of 135.7M. Regarding current trading prices, BIORQ is priced at $0.00, while BRIBF trades at $0.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIORQ currently has a P/E ratio of N/A, whereas BRIBF's P/E ratio is -3.76. In terms of profitability, BIORQ's ROE is +1.22%, compared to BRIBF's ROE of -0.09%. Regarding short-term risk, BIORQ is more volatile compared to BRIBF. This indicates potentially higher risk in terms of short-term price fluctuations for BIORQ.Check BRIBF's competition here
BIORQ vs HBPCF Comparison April 2026
BIORQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIORQ stands at 905. In comparison, HBPCF has a market cap of 132.1M. Regarding current trading prices, BIORQ is priced at $0.00, while HBPCF trades at $1.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIORQ currently has a P/E ratio of N/A, whereas HBPCF's P/E ratio is -43.25. In terms of profitability, BIORQ's ROE is +1.22%, compared to HBPCF's ROE of -0.37%. Regarding short-term risk, BIORQ is more volatile compared to HBPCF. This indicates potentially higher risk in terms of short-term price fluctuations for BIORQ.Check HBPCF's competition here
BIORQ vs AAPGV Comparison April 2026
BIORQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIORQ stands at 905. In comparison, AAPGV has a market cap of 127.3M. Regarding current trading prices, BIORQ is priced at $0.00, while AAPGV trades at $17.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIORQ currently has a P/E ratio of N/A, whereas AAPGV's P/E ratio is N/A. In terms of profitability, BIORQ's ROE is +1.22%, compared to AAPGV's ROE of -1.24%. Regarding short-term risk, BIORQ is more volatile compared to AAPGV. This indicates potentially higher risk in terms of short-term price fluctuations for BIORQ.Check AAPGV's competition here
BIORQ vs TRGNF Comparison April 2026
BIORQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIORQ stands at 905. In comparison, TRGNF has a market cap of 122.6M. Regarding current trading prices, BIORQ is priced at $0.00, while TRGNF trades at $0.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIORQ currently has a P/E ratio of N/A, whereas TRGNF's P/E ratio is -2.58. In terms of profitability, BIORQ's ROE is +1.22%, compared to TRGNF's ROE of -0.64%. Regarding short-term risk, BIORQ is more volatile compared to TRGNF. This indicates potentially higher risk in terms of short-term price fluctuations for BIORQ.Check TRGNF's competition here
BIORQ vs PSTTF Comparison April 2026
BIORQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIORQ stands at 905. In comparison, PSTTF has a market cap of 117.5M. Regarding current trading prices, BIORQ is priced at $0.00, while PSTTF trades at $0.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIORQ currently has a P/E ratio of N/A, whereas PSTTF's P/E ratio is -29.00. In terms of profitability, BIORQ's ROE is +1.22%, compared to PSTTF's ROE of N/A. Regarding short-term risk, BIORQ is more volatile compared to PSTTF. This indicates potentially higher risk in terms of short-term price fluctuations for BIORQ.Check PSTTF's competition here
BIORQ vs JWCTF Comparison April 2026
BIORQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIORQ stands at 905. In comparison, JWCTF has a market cap of 116.6M. Regarding current trading prices, BIORQ is priced at $0.00, while JWCTF trades at $0.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIORQ currently has a P/E ratio of N/A, whereas JWCTF's P/E ratio is -1.40. In terms of profitability, BIORQ's ROE is +1.22%, compared to JWCTF's ROE of -0.75%. Regarding short-term risk, BIORQ is more volatile compared to JWCTF. This indicates potentially higher risk in terms of short-term price fluctuations for BIORQ.Check JWCTF's competition here
BIORQ vs NDTP Comparison April 2026
BIORQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIORQ stands at 905. In comparison, NDTP has a market cap of 112.6M. Regarding current trading prices, BIORQ is priced at $0.00, while NDTP trades at $0.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIORQ currently has a P/E ratio of N/A, whereas NDTP's P/E ratio is -3.52. In terms of profitability, BIORQ's ROE is +1.22%, compared to NDTP's ROE of -0.33%. Regarding short-term risk, BIORQ is more volatile compared to NDTP. This indicates potentially higher risk in terms of short-term price fluctuations for BIORQ.Check NDTP's competition here
BIORQ vs EPRXF Comparison April 2026
BIORQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIORQ stands at 905. In comparison, EPRXF has a market cap of 108.3M. Regarding current trading prices, BIORQ is priced at $0.00, while EPRXF trades at $3.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIORQ currently has a P/E ratio of N/A, whereas EPRXF's P/E ratio is -2.69. In terms of profitability, BIORQ's ROE is +1.22%, compared to EPRXF's ROE of -4.83%. Regarding short-term risk, BIORQ is more volatile compared to EPRXF. This indicates potentially higher risk in terms of short-term price fluctuations for BIORQ.Check EPRXF's competition here
BIORQ vs ADOIF Comparison April 2026
BIORQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIORQ stands at 905. In comparison, ADOIF has a market cap of 103.7M. Regarding current trading prices, BIORQ is priced at $0.00, while ADOIF trades at $8.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIORQ currently has a P/E ratio of N/A, whereas ADOIF's P/E ratio is -2.59. In terms of profitability, BIORQ's ROE is +1.22%, compared to ADOIF's ROE of +6.08%. Regarding short-term risk, BIORQ is more volatile compared to ADOIF. This indicates potentially higher risk in terms of short-term price fluctuations for BIORQ.Check ADOIF's competition here
BIORQ vs MSCLF Comparison April 2026
BIORQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIORQ stands at 905. In comparison, MSCLF has a market cap of 96.6M. Regarding current trading prices, BIORQ is priced at $0.00, while MSCLF trades at $6.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIORQ currently has a P/E ratio of N/A, whereas MSCLF's P/E ratio is 2.43. In terms of profitability, BIORQ's ROE is +1.22%, compared to MSCLF's ROE of -0.70%. Regarding short-term risk, BIORQ is more volatile compared to MSCLF. This indicates potentially higher risk in terms of short-term price fluctuations for BIORQ.Check MSCLF's competition here
BIORQ vs MLLCF Comparison April 2026
BIORQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIORQ stands at 905. In comparison, MLLCF has a market cap of 93.5M. Regarding current trading prices, BIORQ is priced at $0.00, while MLLCF trades at $2.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIORQ currently has a P/E ratio of N/A, whereas MLLCF's P/E ratio is -1.19. In terms of profitability, BIORQ's ROE is +1.22%, compared to MLLCF's ROE of -0.60%. Regarding short-term risk, BIORQ is more volatile compared to MLLCF. This indicates potentially higher risk in terms of short-term price fluctuations for BIORQ.Check MLLCF's competition here
BIORQ vs MCURF Comparison April 2026
BIORQ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIORQ stands at 905. In comparison, MCURF has a market cap of 86.5M. Regarding current trading prices, BIORQ is priced at $0.00, while MCURF trades at $0.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIORQ currently has a P/E ratio of N/A, whereas MCURF's P/E ratio is -16.90. In terms of profitability, BIORQ's ROE is +1.22%, compared to MCURF's ROE of -1.02%. Regarding short-term risk, BIORQ is less volatile compared to MCURF. This indicates potentially lower risk in terms of short-term price fluctuations for BIORQ.Check MCURF's competition here